N-Ethyltryptamine

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by imported>AlyInWikiWonderland at 01:16, 5 April 2025 (Add a paragraph, formatting.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Short description

Template:Drugbox

N-Ethyltryptamine (NET) is a tryptamine that is structurally related to N-methyltryptamine (NMT) and the psychedelic drugs N,N-dimethyltryptamine (DMT) and N,N-diethyltryptamine (DET).[1]

It has been found to act as a potent serotonin 5-HT2A receptor full agonist and serotonin releasing agent.[2]

Alexander Shulgin included NET as an entry in TiHKAL.[1] However, he stated that it had been subjected only to modest human trials and that no active dose level had been identified.[1]

See also

References

<templatestyles src="Reflist/styles.css" />

  1. a b c NET Entry in TIHKAL
  2. Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Template:Serotonin receptor modulators Template:Monoamine releasing agents Script error: No such module "Navbox".